Scarica l'app Stockscreener
30.22
0.60%
0.18
Dopo l'orario di chiusura:
30.58
0.36
+1.19%
Veracyte Inc Borsa (VCYT) Ultime notizie
Veracyte Inc. Builds Base for Possible ReboundPortfolio Return Report & Risk Adjusted Buy/Sell Alerts - newsyoung.net
Trapped Investors in Veracyte Inc. Await Breakout SignalWeekly Loss Report & Short-Term Trading Alerts - sundaytimes.kr
Volatility clustering patterns for Veracyte Inc.Quarterly Profit Review & Long-Term Capital Growth Strategies - Newser
Veracyte Inc.’s volatility index tracking explainedMarket Rally & AI Enhanced Execution Alerts - Newser
Is a relief rally coming for Veracyte Inc. holdersJuly 2025 Momentum & Technical Pattern Based Signals - Newser
Forecasting Veracyte Inc. price range with options data2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Real time alert setup for Veracyte Inc. performanceInsider Buying & Stock Portfolio Risk Control - Newser
Is now a turning point for Veracyte Inc.July 2025 Sentiment & Stock Market Timing Techniques - Newser
Why Veracyte Inc. stock attracts strong analyst attentionWeekly Loss Report & Daily Momentum Trading Reports - Newser
Here's Why Veracyte (VCYT) is a Strong Growth Stock - Yahoo Finance
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality - Yahoo Finance
Veracyte Inc. Inches Above Key Support — Safe to HoldJuly 2025 Institutional & Free Real-Time Volume Trigger Notifications - thegnnews.com
PNC Financial Services Group Inc. Cuts Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
How Resilient Is Veracyte Inc. Stock During Economic Downturns2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - Newser
Veracyte, Inc. (NASDAQ:VCYT) Shares Purchased by Blair William & Co. IL - Defense World
VCYT Stock Gains on Q2 Earnings and Revenue Beat, Margins Up - TradingView
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Is Veracyte Inc. a Top Dividend Stock to Watch in 2025Price Movement and Market Sentiment Analysis - Newser
Candlestick Signal Suggests Reversal in Veracyte Inc.Chart-Based Trade Entries Gain Analyst Support - metal.it
Veracyte stock price target lowered to $28 from $29 at Morgan Stanley By Investing.com - Investing.com South Africa
Veracyte stock price target lowered to $28 from $29 at Morgan Stanley - Investing.com Australia
Cautious Outlook on Veracyte: Sell Rating Amid Market Uncertainties and Valuation Concerns - TipRanks
Veracyte price target lowered to $28 from $29 at Morgan Stanley - TipRanks
A Quick Look at Today's Ratings for Veracyte(VCYT.US), With a Forecast Between $41 to $45 - 富途牛牛
Veracyte, Inc. (NASDAQ:VCYT) Q2 2025 Earnings Call Transcript - Insider Monkey
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight - GuruFocus
Veracyte Inc’s Earnings Call Highlights Robust Growth and Strategic Milestones - TipRanks
Veracyte Receives Buy Rating and $37 Price Target from Guggenheim Analyst - AInvest
Veracyte’s Strong Financial Performance and Promising Growth Prospects Justify Buy Rating - TipRanks
Helix and Veracyte Partner to Expand Access to Clinically Actionable Genomic Insights in Prostate Cancer Care - AInvest
Veracyte (VCYT) Q2 Revenue Jumps 14% - AOL.com
Veracyte stock rating reiterated at Outperform by William Blair - Investing.com India
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls - Investing.com Canada
Earnings call transcript: Veracyte’s Q2 2025 earnings beat expectations, stock falls By Investing.com - Investing.com South Africa
Veracyte's 2025 Q2 Financial Performance and Strategic Momentum: A Deep Dive into Diagnostic Innovation and Oncology Expansion - AInvest
Veracyte: Q2 Earnings Snapshot - Greenwich Time
Veracyte Announces Second Quarter 2025 Financial Results - BioSpace
Veracyte's 2025 Earnings Call: A Catalyst-Driven Path to Sustained Double-Digit Growth and 25%+ Adjusted EBITDA Margins - AInvest
Veracyte Reports Strong Q2 2025 Revenue Growth - TipRanks
Veracyte’s Revenue Growth Outpaces Forecasts And Lifts Guidance - Finimize
Veracyte (VCYT) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
Veracyte Q2 2025 slides: Decipher drives 14% revenue growth, EBITDA margins expand - Investing.com Nigeria
Veracyte Q2 revenue rises 14%, beats expectations - MarketScreener
Veracyte Inc (VCYT) Q2 2025 Earnings: Revenue Surpasses Estimates at $130.2M, Reports GAAP Net Loss - GuruFocus
Veracyte shares surge as Q2 profits quadruple expectations By Investing.com - Investing.com Nigeria
Veracyte Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Veracyte shares surge as Q2 profits quadruple expectations - Investing.com
Veracyte Inc earnings beat by $0.33, revenue topped estimates - Investing.com Canada
Veracyte reports Q2 EPS 44c, consensus 30c - TipRanks
0.67%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):